Capital Flow Monitor · Sponsors · CIK 1782236
Reprise Biomedical, Inc.
17400 Medina Rd., Ste. 100, Plymouth, MN, 55447 · 763-284-6780
Biotechnology · Corporation· inc. MINNESOTA true
Fit score
—
Offering
$10.0M
Sold
$9.2M
% sold
92.5%
Investors
43
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | D/A ·current | 506(b) | $10.0M | $9.2M | 92.5% | 43 | EDGAR ↗ |
| 2026-05-21 | D | 506(b) | $8.0M | $1.5M | 18.1% | 4 | EDGAR ↗ |
| 2025-07-11 | D | 506(b) | $7.0M | $6.4M | 90.8% | 14 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Carrie Powers — Executive Officer / Director, Plymouth, MN
- Jake Isenburg — Executive Officer, Plymouth, MN
- Tom Kouchoukos — Executive Officer, Plymouth, MN
- Steve Jagodzinski — Executive Officer, Plymouth, MN
- Greg Smock — Executive Officer, Plymouth, MN
- Jerrod Krueger — Executive Officer, Plymouth, MN
- Heather Kotila — Executive Officer, Plymouth, MN
- Howard Root — Director, Plymouth, MN
- Ronald Eibensteiner — Director, Plymouth, MN
-
Erwin Kelen — Director, Plymouth, MN
1 other raise
- Aleran Software, Inc. $3.1M of $7.0M · 43.9%
- Phil Nalbone — Director, Plymouth, MN
- Alan Woldt — Director, Plymouth, MN
- Jeff Duncan — Executive Officer, Plymouth, MN
Placement agents
- Cedar Point Capital, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.